Home | Welcome to Contract Pharma   
Last Updated Thursday, November 20 2014
Print

Online Exclusives

Related Searches:
Kristin Brooks
November 12, 2014
New immunology applications aim to further enhance discovery efforts  Read More »
July 23, 2014
In a recent video interview on 3B Nexus, the company's CEO discussed GSK's pipeline and strategy, and the potential of its recent deal with Novartis.   Read More »
Reinventing Pharma Through Lean Six Sigma
July 23, 2014
The principles of Lean Six Sigma can be applied throughout the pharmaceutical value chain, from early project selection through clinical trials, manufacturing and distribution. A new book by quality and operational excellence expert, and Pharmatech president Bikash Chatterjee, examines issues, realities and possibilities. Included is a sample book chapter.   Read More »
July 23, 2014
You may know FMEA, Fault Tree and Fishbone methods, but do you know Bow-Tie risk assessment practices? Proven in aerospace and oil & gas industries, they can help strengthen top management connection to key areas of potential vulnerability.  Read More »
July 23, 2014
LRN's Latest Ethics and Compliance Program Effectiveness Report examines ethics and compliance across industries and finds that pharma still lags behind other industries. The report points to potential reasons and issues.   Read More »
July 23, 2014
Would you like to share your expertise in a case study or best practices article, or even just share a brief opinion in a blog post or commentary? Please consider writing for the Contract Pharma community. We've just updated our Writers' Guidelines to provide more input on graphics, and even received some unexpected help from a brand new expert named Al Yankovic.   Read More »
July 2, 2014
One BIO talk discussed transforming operations after a Consent Decree   Read More »
Kristin Brooks
June 24, 2014
What’s being done to streamline drug development, and the past, present, and future of outsourced services  Read More »
Kristin Brooks
May 28, 2014
Karen Noonan addresses biosimilars, orphan drug development and supportive efforts aimed at a stronger FDA   Read More »
Kristin Brooks
March 28, 2014
Erin Bosman of Morrison & Foerster explores potential repercussions  Read More »
Agnes Shanley
March 20, 2014
A brief report from DCAT 2014  Read More »
Agnes Shanley
March 20, 2014
You’ve read our Interphex newsletters, but we will also report on what we saw first hand at this year’s show.  Interphex 2014 was quite different from previous shows, with a new conference format, and it even featured a BIO-like gran…  Read More »
Kristin Brooks
March 17, 2014
Raghu Chintala discusses ICON’s e-clinical solutions and their impact on trials  Read More »
Kristin Brooks
March 3, 2014
Q&A with Tom Arneman of Ceiba Solutions addresses challenges and trends  Read More »
Kristin Brooks
February 25, 2014
Q&A with Birgit Girshick about the insourcing/outsourcing service for pharma and biopharma  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On